Incannex Healthcare (IXHL) Other Operating Expenses (2024)

Incannex Healthcare (IXHL) posted quarterly Other Operating Expenses of -$1.1 million for Q4 2024.

Incannex Healthcare (IXHL) Other Operating Expenses (2024) Analysis & Trends

Incannex Healthcare (IXHL) has reported Other Operating Expenses for 1 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2024.

  • Quarterly Other Operating Expenses changed N/A year-over-year to -$1.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (changed N/A YoY) and the FY2025 annual result came in at -$932000.0, down 13.24% from the prior year.
  • Other Operating Expenses was little changed at -$1.1 million in Q4 2024 per IXHL's latest filing.
  • Over the last five years, Other Operating Expenses for IXHL reached as high as -$1.1 million in Q4 2024 and fell as low as -$1.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.10 Mn